Read More 2 minute read Pharma Industry News Nasodine Nasal Spray phase 3 clinical trial : Firebrick Pharma completes 82% patient recruitment Firebrick Pharma, an ASX-listed pharmaceutical company, announced that it has successfully enrolled 160 subjects in the confirmatory phase… byPallavi MadhirajuMay 31, 2023